Efficacy and Safety of Tolvaptan in Heart Failure Patients With Volume Overload-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of Tolvaptan in Heart Failure Patients With Volume Overload

Published:2014 Issue:4 Volume:78 Page:844-852
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Kinugawa Koichiro¹,Sato Naoki²,Inomata Takayuki³,Shimakawa Toshiyuki⁴,Iwatake Noriaki⁴,Mizuguchi Kazuki⁴

Affiliation:

1. Department of Therapeutic Strategy for Heart Failure, Graduate School of Medicine, University of Tokyo

2. Internal Medicine and Cardiology, Nippon Medical School Musashi-Kosugi Hospital

3. Department of Cardiovascular Medicine, Kitasato University School of Medicine

4. Otsuka Pharmaceutical Co, Ltd

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/78/4/78_CJ-14-0126/_pdf

Reference27 articles.

1. 1. Brater DC, Chennavasin P, Seiwell R. Furosemide in patients with heart failure: Shift in dose-response curves. Clin Pharmacol Ther 1980; 28: 182–186.

2. 2. Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, et al. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 2002; 105: 1348–1353.

3. 3. Vasko MR, Cartwright DB, Knochel JP, Nixon JV, Brater DC. Furosemide absorption altered in decompensated congestive heart failure. Ann Intern Med 1985; 102: 314–318.

4. 4. Felker GM. Loop diuretics in heart failure. Heart Fail Rev 2012; 17: 305–311.

5. 5. Cowie MR, Komajda M, Murray-Thomas T, Underwood J, Ticho B, POSH Investigators. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: Results of the prospective outcomes study in heart failure (POSH). Eur Heart J 2006; 27: 1216–1222.

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of hypernatremia on the microglia;Peptides;2024-09

2. The potential effectiveness of tolvaptan independent of cardiac disease in critically ill patients: A retrospective observational study;2023-10-23

3. The clinical effectiveness of tolvaptan in critically ill patients with or without heart disease: A retrospective observational study;2023-05-11

4. Hyponatremia Associated with Congestive Heart Failure: Involvement of Vasopressin and Efficacy of Vasopressin Receptor Antagonists;Journal of Clinical Medicine;2023-02-13

5. Efficacy of tolvaptan on advanced chronic kidney disease with heart failure: a randomized controlled trial;Clinical and Experimental Nephrology;2022-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3